Active
Commercial

Streamline Investment Group III Fund

Medical & Class B Office Buildings

Mesa, AZ

Target Return
15.00%
Minimum
$50,000
Hold Period
60 Months
Total Raise
$15,000,000

Sponsored by Streamline Capital Group, LLC

owner
Active
Commercial

Streamline Investment Group III Fund

Medical & Class B Office Buildings

Mesa, AZ

Target Return
15.00%
Minimum
$50,000
Hold Period
60 Months
Total Raise
$15,000,000

Sponsored by Streamline Capital Group, LLC

owner

Overview

Equity
Regulation D 506(c)
Balanced

Streamline Investment Group III offers accredited investors access to high-performing medical and Class B office buildings in Phoenix—leased to healthcare and essential service tenants on long-term agreements. With an 8% preferred return, 15% targeted IRR, and upside driven by strategic renovations and active asset management, our vertically integrated model ensures cost control, efficiency, and hands-free ownership. Back…

8% Preferred Return
15% Target IRR
Multi-Property Fund
80/20 Split
Medical Office
Class B Office

Sponsored by Streamline Capital Group, LLC

Accredited Investors Only
owner

Or

Relli connects investors with exclusive real estate opportunities by acting as a trusted intermediary. Our marketplace is comprised of experienced sponsors, curating a pipeline of deals that match your investment criteria. This means you gain direct access to high-quality real estate sponsors without paying a commission.

Our sponsors are seasoned real estate professionals with strong backgrounds and a proven track record of success. We work exclusively with sponsors who have demonstrated expertise and deep industry knowledge, ensuring that every opportunity on our platform meets rigorous standards of quality and performance.

No, Relli is a commission-free platform. Our business model is designed to connect you directly with the sponsor, so you invest in the deal without paying any extra fees. This transparent approach ensures that more of your capital works for you, aligning our success with your investment outcomes.


Or